Publication Date
3-18-2022
Journal
iScience
DOI
10.1016/j.isci.2022.103923
PMID
35252817
PMCID
PMC8891954
PubMedCentral® Posted Date
2-14-2022
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
Oncology, Pathology, Omics
Abstract
Bulk and single-cell RNA sequencing do not provide full characterization of tissue spatial diversity in cancer samples, and currently available in situ techniques (multiplex immunohistochemistry and imaging mass cytometry) allow for only limited analysis of a small number of targets. The current study represents the first comprehensive approach to spatial transcriptomics of high-grade serous ovarian carcinoma using intact tumor tissue. We selected a small cohort of patients with highly annotated high-grade serous ovarian carcinoma, categorized them by response to neoadjuvant chemotherapy (poor or excellent), and analyzed pre-treatment tumor tissue specimens. Our study uncovered extensive differences in tumor composition between the poor responders and excellent responders to chemotherapy, related to cell cluster organization and localization. This in-depth characterization of high-grade serous ovarian carcinoma tumor tissue from poor and excellent responders showed that spatial interactions between cell clusters may influence chemo-responsiveness more than cluster composition alone.
Graphical Abstract
Included in
Medical Sciences Commons, Obstetrics and Gynecology Commons, Oncology Commons, Pathology Commons, Women's Health Commons
Comments
Associated Data